Know Cancer

or
forgot password

    • cancer clinical trials in glendora, CA

    • TAC Versus TC for Adjuvant Breast Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Breast Cancer
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Breast Cancer
    Trial of Poor Performance Status Patients (ToPPS)
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Non Small Cell Lung Cancer
    Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Metastatic Breast Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Malignant Pleural Mesothelioma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Peripheral T-cell Lymphoma
    Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Myelodysplastic Syndrome
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Carcinoma, Squamous Cell of the Head and Neck
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Citrus Valley Medical Research, Inc.
    Glendora, California 91741
    Overactive Bladder
    A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    Expressed Prostatic Secretion and Post Massage Urine Biomarkers in Predicting Biopsy Results in Patients Undergoing Prostate Biopsy
    Citrus Valley Urologic Medical Group
    Glendora, California 91741
    Conditions Influencing Health Status, Healthy, Prostate Cancer
    A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Eflornithine in Treating Patients With Bladder Cancer
    Citrus Valley Urological Medical Group
    Glendora, California 91741-4164
    Bladder Cancer
    Clinical Trial for Ovarian Cancer (OvaRex®)
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Ovarian Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Carcinoma, Non-Small-Cell Lung
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Non-Hodgkin's Lymphoma
    STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer
    STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Hematological Malignancies, Leukemia, Lymphoma, Metastatic or Unresectable Solid Tumors
    Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
    Wilshire Oncology Medical Group
    Glendora, California 91741
    B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Ovarian Cancer, Endometrial Cancer
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    Wilshire Oncology Medical Group
    Glendora, California 91741
    Non-small Cell Lung Cancer
    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
    Wilshire Oncology Medical Group
    Glendora, California 91741
    First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis